The amendments made in the Therapeutic Goods Amendment (2011 Measures No. 1) Bill 2011 are designed to improve processes for the evaluation of prescription medicines, the collection of evaluation fees payable for prescription medicines and the imposition of standard conditions on registered and listed therapeutic goods by way of a legislative instrument. I thank senators for their contributions and I commend this bill to the Senate.

Question agreed to.

Bill read a second time.